June Ann Seymour's Stock Option Grant at Cartesian Therapeutics

On October 27, 2025, June Ann Seymour, the Chief Accounting Officer of Cartesian Therapeutics, Inc., was granted 50,000 employee stock options. These options, which are rights to buy common stock, have an exercise price of $8.85 and expire on October 27, 2035. The options vest in four equal annual installments, starting on October 27, 2026, with full vesting achieved by October 27, 2029. This transaction was reported in a Form 4 filing with the SEC.